Matches in Wikidata for { <http://www.wikidata.org/entity/Q93210292> ?p ?o ?g. }
Showing items 1 to 49 of
49
with 100 items per page.
- Q93210292 description "article scientifique publié en 2020" @default.
- Q93210292 description "artículu científicu espublizáu n'abril de 2020" @default.
- Q93210292 description "scientific article published on 01 April 2020" @default.
- Q93210292 description "wetenschappelijk artikel" @default.
- Q93210292 description "наукова стаття, опублікована 1 квітня 2020" @default.
- Q93210292 name "151 Confirmed Safety of Deutet.rabenazine for Tardive Dyskinesia in a 3-Year Open-Label Extension Study" @default.
- Q93210292 name "151 Confirmed Safety of Deutet.rabenazine for Tardive Dyskinesia in a 3-Year Open-Label Extension Study" @default.
- Q93210292 type Item @default.
- Q93210292 label "151 Confirmed Safety of Deutet.rabenazine for Tardive Dyskinesia in a 3-Year Open-Label Extension Study" @default.
- Q93210292 label "151 Confirmed Safety of Deutet.rabenazine for Tardive Dyskinesia in a 3-Year Open-Label Extension Study" @default.
- Q93210292 prefLabel "151 Confirmed Safety of Deutet.rabenazine for Tardive Dyskinesia in a 3-Year Open-Label Extension Study" @default.
- Q93210292 prefLabel "151 Confirmed Safety of Deutet.rabenazine for Tardive Dyskinesia in a 3-Year Open-Label Extension Study" @default.
- Q93210292 P1433 Q93210292-A4EA365D-C673-4DED-B9B6-A35CAE8EB1F2 @default.
- Q93210292 P1476 Q93210292-39CB7DAA-D153-4854-BE04-B51FE092D9F9 @default.
- Q93210292 P2093 Q93210292-026E511A-FE3C-4091-A244-CF49AF5AF22E @default.
- Q93210292 P2093 Q93210292-482A8103-9905-4EB5-9D22-C94294EAC22B @default.
- Q93210292 P2093 Q93210292-692FA33A-5DC0-4F19-8B1F-30548B7E3A8A @default.
- Q93210292 P2093 Q93210292-74C0926C-C3AD-4F5B-B57E-0ABBEF8729FA @default.
- Q93210292 P2093 Q93210292-7886A6B3-B632-4BA4-B4E7-7F02E956DD87 @default.
- Q93210292 P2093 Q93210292-8A0FA75B-ED54-4DE7-A5E3-AF9861576F79 @default.
- Q93210292 P2093 Q93210292-8F290761-0A44-4704-AD48-938F42A6B6BD @default.
- Q93210292 P2093 Q93210292-A9FB4B02-B54E-490C-A8EF-2BA33D44D60B @default.
- Q93210292 P2093 Q93210292-DC697698-E7E6-444C-8D2B-F6CDFC3ED76E @default.
- Q93210292 P2093 Q93210292-EBDCF641-BD14-426E-9078-F58995198612 @default.
- Q93210292 P304 Q93210292-5A467A9E-F723-4AFE-97C4-B8607C58A907 @default.
- Q93210292 P31 Q93210292-26DCC88C-81F1-4743-9347-C171B46B3A77 @default.
- Q93210292 P356 Q93210292-767A47B3-3A85-49D0-892D-CA0B37BE8F15 @default.
- Q93210292 P433 Q93210292-0A325DF2-67F4-4164-9555-B5C6C39722D4 @default.
- Q93210292 P478 Q93210292-FCD21B03-468A-4CE5-921D-A705E0D973B1 @default.
- Q93210292 P577 Q93210292-DFA10668-5318-4969-8E45-09EFE88AAE5C @default.
- Q93210292 P356 S109285292000067X @default.
- Q93210292 P1433 Q15750260 @default.
- Q93210292 P1476 "151 Confirmed Safety of Deutet.rabenazine for Tardive Dyskinesia in a 3-Year Open-Label Extension Study" @default.
- Q93210292 P2093 "Hadas Barkay" @default.
- Q93210292 P2093 "Hubert H Fernandez" @default.
- Q93210292 P2093 "Joohi Jimenez-Shahed" @default.
- Q93210292 P2093 "Juha-Matti Savola" @default.
- Q93210292 P2093 "Karen E Anderson" @default.
- Q93210292 P2093 "Leslie Marinelli" @default.
- Q93210292 P2093 "Mark Forrest Gordon" @default.
- Q93210292 P2093 "Nicholas Gross" @default.
- Q93210292 P2093 "Robert A Hauser" @default.
- Q93210292 P2093 "Stewart A Factor" @default.
- Q93210292 P304 "296-297" @default.
- Q93210292 P31 Q13442814 @default.
- Q93210292 P356 "10.1017/S109285292000067X" @default.
- Q93210292 P433 "2" @default.
- Q93210292 P478 "25" @default.
- Q93210292 P577 "2020-04-01T00:00:00Z" @default.